New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2013
10:01 EDTMIICF, HCN, PVH, PWRD, EVER, INFY, AMX, AVG, CSCO, RHT, CVS, AGU, BKD, CDNS, DRYS, RSHOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: CVS Caremark (CVS) downgraded to Neutral from Buy at Goldman... EverBank Financial (EVER) downgraded to Neutral from Buy at Sterne Agee... RadioShack (RSH) downgraded to Sell from Neutral at Goldman... Red Hat (RHT) downgraded to Neutral from Buy at Citigroup... Perfect World (PWRD) downgraded to Neutral from Buy at Citigroup... DryShips (DRYS) downgraded to Underperform from In-Line at Imperial Capital... Cisco (CSCO) downgraded to Hold from Buy at Standpoint Research... PVH Corp. (PVH) downgraded to Neutral from Overweight at Piper Jaffray... Cadence Design (CDNS) downgraded to Neutral from Buy at DA Davidson... AVG Technologies (AVG) downgraded to Equal Weight from Overweight at Morgan Stanley... Health Care REIT (HCN) downgraded to Neutral from Outperform at Macquarie... Brookdale Senior Living (BKD) downgraded to Underperform from Neutral at Macquarie... America Movil (AMX) downgraded to Neutral from Outperform at Credit Suisse... Millicom (MIICF) downgraded to Neutral from Overweight at HSBC... Infosys (INFY) downgraded to Negative from Neutral at Susquehanna... Agrium (AGU) downgraded to Market Perform from Outperform at BMO Capital.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
November 23, 2015
14:10 EDTCVSAmgen's PCSK9 inhibitor Repatha gets exclusive deal with CVS
Subscribe for More Information
09:21 EDTCVSConsolidated Tomoka disposes non-core income property for about $5.4M
Subscribe for More Information
November 20, 2015
10:38 EDTRHTAnalyst sees 'cloud cold war' coming between Google, Microsoft, Amazon
Recent comments by Google (GOOG) indicate that the tech giant plans to make a major push in the cloud infrastructure market, Deutsche Bank analyst Ross Sandler wrote in a note to investors today. Google's initiatives in this area could significantly boost its stock price and signify the start of a "cold war" in the space, but are unlikely to negatively affect the number two player in the area, Microsoft (MSFT), Sandler believes. WHAT'S NEW: Google has not been aggressively expanding its cloud infrastructure business, but recent comments by the tech giant indicates that this situation is changing, Sandler wrote. Google executive Urs Holzle said that the tech giant plans to aggressively expand its cloud platform, and projected that the company's revenue from the cloud could surpass its ad revenue by 2020, the analyst noted. The note comes after Google acquired a small platform-as-a-service company called bebop and appointed its CEO, VmWare (VMW) co-founder Diane Greene, to lead a new cloud business. Based on Hozle's comment, Google is seeking to boost its cloud revenue to $100B by 2020, Sandler estimated. If the tech giant even "gets part of the way" to meeting the goal, the growth in its cloud business will boost its market cap by hundreds of billions of dollars, Sandler believes. Google's push in the cloud is negative for Microsoft, but it will take years for Google to build up its cloud business to the point where it's competitive with Microsoft's cloud offering, Azure, the analyst contended. Amazon (AMZN), which Google also much catch, is the runaway leader in the cloud market. WHAT'S NOTABLE: Google may look to make acquisitions in the software-as-a-service sector to build up its cloud business, and vendors like Red Hat (RHT) which sell to cloud infrastructure providers have added a major new customer, Sandler wrote. Major software-as-a-service providers include (CRM), Workday (WDAY), and Netsuite (N). PRICE ACTION: In early trading, Alphabet Class A shares gained 1.5% to $771.37, Microsoft slid 1.1% to $53.33 and Amazon rose fractionally to $662.87.
08:04 EDTCSCOCisco announces intent to acquire Acano for $700M in cash, assumed equity awards
Subscribe for More Information
08:03 EDTCSCOCisco announces intent to acquire Acano for $700M in cash, assumed equity awards
06:13 EDTCSCOTechnicolor completes $600M Cisco Connected Devices acquisition
Subscribe for More Information
November 19, 2015
07:15 EDTRHTPalo Alto Fortinet seen as potential Cisco takeover targets, says Oppenheimer
Subscribe for More Information
05:54 EDTCSCOCisco implied volatility of 18 at lower end of index mean range
Subscribe for More Information
November 18, 2015
15:40 EDTCVSCongressman says U.S. may need look at pharmacy competition, dealReporter says
Subscribe for More Information
11:01 EDTCVSTarget says working with CVS team to secure regulatory approval for deal
Target (TGT) says "pleased" with progress to date of CVS (CVS) deal.
08:08 EDTRHTWipro announces collaboration with Red Hat
Subscribe for More Information
07:59 EDTCSCOUBS to hold a conference
Subscribe for More Information
November 17, 2015
16:01 EDTCSCOOptions Update; November 17, 2015
iPath S&P 500 VIX Short-Term Futures up 1.32 to 21.07. Option volume leaders: GE BAC AAPL FB NFLX SYF WMT CSCO MU SUNE VRX BABA AMZN HD FCX
10:17 EDTCVSHouse Judiciary Committee to hold a hearing
The Subcommittee on Regulatory Reform, Commercial and Antitrust Law holds a hearing entitled, "The State of Competition in the Pharmacy Benefit Manager and Pharmacy Marketplaces" with Vice President Bricker of Express Scripts and Senior Vice President Pons of CVS Health on November 17 at 3 pm. Webcast Link
09:05 EDTEVEREverBank initiated with a Hold at Sandler O'Neill
Subscribe for More Information
06:33 EDTAMXAmerica Movil downgraded to Neutral from Outperform at Macquarie
Subscribe for More Information
November 16, 2015
09:06 EDTCVSDiplomat seen as compelling amid specialty pharmacy fallout
Shares of specialty pharmacy operator Diplomat Pharmacy (DPLO) and pharmacy benefit manager Express Scripts (ESRX) have each been knocked down by the negative news surrounding the sector amid the troubles faced by Valeant (VRX) and others, but an analyst at Leerink contends in a note to investors that the pullbacks in both stocks provide buying opportunities. BACKGROUND: Drugmaker Valeant and its prior specialty pharmacy partner, Philidor Rx Services, have been at the center of the firestorm engulfing the sector. Following claims that Philidor urged its employees to modify prescriptions to ensure more orders of Valeant-branded drugs rather than generics, as well as other allegations of wrongdoing, Express Scripts (ESRX) and peer CVS Health (CVS) terminated Philidor from their networks. The day after those termination announcements, Valeant said that it was severing all ties with Philidor and that the pharmacy planned to shut down operations as soon as possible, consistent with applicable laws. Valeant has subsequently said that Philidor has committed to cease operations by January 30, 2016, at the latest. More recently, Express Scripts, the nation's largest pharmacy benefit manager, announced that it stopped doing business with Linden Care, accusing it of being a "captive" pharmacy that dispenses mostly products made by Horizon Pharma (HZNP). In turn, Horizon called the idea that Linden Care is a captive pharmacy "entirely false," stating that "at best Express Scripts is being reckless in its allegations and at worse it is intentionally attempting to mislead investors." Express Scripts' move also impacted shares of Insys Therapeutics (INSY), which reportedly also used Linden Care to fulfill prescription for its drugs. DIPLOMAT LIKELY TO STAY IN-NETWORK: Leerink analyst David Larsen acknowledged that recent events indicate that Express Scripts appears to be evaluating certain retail pharmacies and their relationships with manufacturers, but he believes Diplomat's mix of drugs for diseases like multiple sclerosis, HIV, hepatitis C and cancer differentiate it as a "true" specialty pharmacy. Larsen does not think Diplomat is at risk of being excluded from the pharmacy networks of Express Scripts, CVS or UnitedHealth's (UNH) Optum, he tells investors. Larsen expects limited distribution agreements to stay an important channel strategy for drugmakers and believes these agreements are appropriate for high cost specialty drugs that require special handling and additional services to manage patient adherence. The analyst, who thinks Diplomat remains well positioned to deliver annual growth of over 30% in the next several years, keeps an Outperform rating on its shares. EXPRESS BUYING OPPORTUNITY: Larsen also thinks concerns around manufacturer and pharmacy relationships have put unwarranted pressure on shares of Express Scripts. He does not expect Express Scripts to disclose new lawsuits around rebate dollars owed over other manufacturer disputes and keeps an Outperform rating on the stock, which he views as having an "attractive" valuation. WHAT'S NOTABLE: Larsen also thinks that the specialty channel remains an opportunity for Walgreens Boots Alliance (WBA) and believes its proposed acquisition of Rite Aid (RAD) can strengthen its specialty offering. The analyst keeps an Outperform rating on Walgreens shares as well. PRICE ACTION: Over the last three months, Diplomat Pharmacy shares have declined 28%, Express Scripts has fallen 6% and Walgreens has dropped 14%.
06:54 EDTPVHPVH Corp. risk/reward favorable after selloff, says Piper Jaffray
Subscribe for More Information
06:18 EDTCVSDiplomat Pharmacy selloff brings 'compelling' entry point, says Leerink
Subscribe for More Information
05:26 EDTCSCOEricsson CEO says no talks with Cisco about merger or acquisition
Ericsson (ERIC) has noted the recent speculation in the press and financial markets regarding an interest by Cisco (CSCO) to acquire Ericsson. On November 9, the two companies announced a global business and technology partnership to create the networks of the future. The partnership announcement was supported by multiple agreements that include commitments to network transformation through reference architectures and joint development, systems-based management and control, a broad reseller agreement, and collaboration in key emerging market segments. President, CEO and member of the board, Hans Vestberg says: "We note that there are rumors in the market regarding an acquisition of Ericsson by Cisco possibly spurred by the recent announcement of a partnership between our two companies. The talks leading up to the partnership announcement have been ongoing for a year and there have not been any discussions whatsoever on a merger or an acquisition."
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use